DMEMEDS shared post via Reuters: India's Ranbaxy gets FDA approval for Novartis's Diovan generic

WASHINGTON/MUMBAI (Reuters) - India's Ranbaxy Laboratories Ltd has received approval from the U.S. Food and Drug Administration (FDA) to launch a cheaper copy of Novartis AG's blood pressure pill Diovan, bolstering its outlook after a raft of regulatory bans for poor production quality at its India facilities dented investor sentiment. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/ZziWRqOLOoM/story01.htm

Read More